Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma.
Authors: Turner JG; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida. joel.turner@moffitt.org dmsbigsky@gmail.com., Cui Y; Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Bauer AA; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida., Dawson JL; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida., Gomez JA; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida., Kim J; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, Florida., Cubitt CL; Translational Research Core, Moffitt Cancer Center and Research Institute, Tampa, Florida., Nishihori T; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida.; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, Florida., Dalton WS; Department of Malignant Hematology, Moffitt Cancer Center and Research Institute, Tampa, Florida., Sullivan DM; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center and Research Institute, Tampa, Florida. joel.turner@moffitt.org dmsbigsky@gmail.com.; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center and Research Institute, Tampa, Florida.
Source: Cancer research [Cancer Res] 2020 Dec 01; Vol. 80 (23), pp. 5344-5354. Date of Electronic Publication: 2020 Oct 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-19-0677